Skip to content
Recall Observatory FDA recall evidence

Device product

Oblique Posterior Atraumatic Lumbar (OPAL) System, Polymeric spinal fusion cage, non-sterile, OPAL Spacer 10 mm x 24 mm, 11 mm Height - Revolve Product Usage - The OPAL Spacer is indicated for use in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1 whose condition requires the use of interbody fusion combined with supplemental fixation. The interior of the OPAL Spacer should be packed with autogenous bone graft (i.e. autograft). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months or non-operative treatment. The OPAL Spacer is intended to be used with Synthes supplemental fixation, e.g. TSLP, ATB, Antegra, Pangea, USS Including ClickX) and small stature USS.

Z-1392-2016

February 18, 2016

Class II

Product summary

Firm
Synthes (USA) Products LLC
Event
Event 73552
Status
Terminated
Classification
Class II
Quantity
6 units
Official record key
device-enforcement:Z-1392-2016

Official wording

Reason: The label on the outer packaging does not match the product inside and intended use of the device.

Code information: Lot # 9984134, Catalog ID 08.803.051, OPAL Spacer 10 mm x 24 mm, 11 mm Height - Revolve

Distribution pattern: Distributed in the US: OH and ND

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The label on the outer packaging does not match the product inside and intended use of the device.